Delhi HC Bangs AAP Government Over Covaxin Shortage
The Delhi High Court, on June 2, rapped the Aam Aadmi Party (AAP) government for not being able to provide a second dose of Bharat...
Tag : Bharat Biotech
Bharat Biotech to Start Trials of Covaxin 2 to 18 Age Group
The Phase 2-3 clinical trials of Covid-19 vaccine, Covaxin, has been approved by the Drugs Controller General of India (DCGI), for in the age group...
Vaccine Makers Invited To Produce Covaxin
The central government and Bharat Biotech are willing to invite other companies which want to produce Covaxin to help scale up its production, a top...
Covaxin to be Sold at Rs 600 to States, Rs 1,200 to Pvt Hospitals
Bharat Biotech announced on April 24 that its COVID-19 vaccine Covaxin will be sold at Rs 600 per dose to states, and Rs 1,200 per...
SII Fixes Covishield Price At Rs 400 For States, 600 For Pvt Hospitals
The Serum Institute of India (SII) has announced that it will price its Covishield vaccine at Rs 600 per dose for private hospitals and Rs...
India to Waive Import Duty on Covid-19 Vaccine
The government is likely to waive a 10 per cent customs duty levied on imported vaccines in a bid to keep low the cost of...
DCGI Approves Use of Sputnik V Vaccine
The Drug Controller General of India (DCGI) has approved the restricted emergency use of the Sputnik V vaccine late Monday night. With this, India now...
PM Gets Second Dose of COVID-19 Vaccine
Prime Minister Narendra Modi received his second dose of the Covid vaccine today at AIIMS Delhi – 37 days after his first shot – and...
Ocugen Seeks to Sell 100 Mn Bharat Biotech’s Covaxin Doses in US in 2021
Ocugen Inc seeks to sell 100 million doses of India’s state-backed COVID-19 vaccine COVAXIN in the United States this year, the US firm’s Chief Executive...
PM Modi Takes 1st Dose of Covid Vaccine at AIIMS Delhi
Prime Minister Narendra Modi on Monday took the first dose of Covaxin, India’s homegrown coronavirus vaccine developed by biotechnology firm Bharat Biotech and the Indian...